Item Details

Therapeutic Immunology

by K. Frank Austen ... [et al.]
Format
Book
Published
Malden, MA : Blackwell Science, c2001.
Edition
2nd ed
Language
English
ISBN
0632043598
Contents
  • Ch. 1. Adaptive immunity
  • Ch. 2. Innate immunity and instruction of the adaptive immune response
  • Ch. 3. Cyclophosphamide
  • Ch. 4. The purine antagonists: Azathioprine and Mycophenolate Mofetil
  • Ch. 5. Methotrexate
  • Ch. 6. Immunosupression and immunophilin binding agents: current research and clinical applications
  • Ch. 7. Glucocorticoid action
  • Ch. 8. Cyclooxygenase inhibitors
  • Ch. 9. Antileukotrienes (leukotriene modifiers) in the treatment of asthma
  • Ch. 10. Phosphodiesterase inhibitors
  • Ch. 11. Tryptase inhibitors
  • Ch. 12. 5-Aminosalicylic acid (mesalamine) and sulfasalazine
  • Ch. 13. Antihistamines (H₁-receptor antagonists)
  • Ch. 14. Hematopoietic growth factors
  • Ch. 15. Cytokines regulating immune inflammation: Interleukin-4, Interleukin-10, and Interleukin-12
  • Ch. 16. The interferons: basic biology and therapeutic potential
  • Ch. 17. Interleukin-2 immunostimulation
  • Ch. 18. A soluble TNF receptor-Fc fusion protein (etanercept) in the treatment inflammatory diseases
  • Ch. 19. Intravenous immunoglobulin therapy
  • Ch. 20. Therapeutic inhibition of complement activation with emphasis on drugs in clinical trials
  • Ch. 21. Treatment of angioedema resulting from C1-inhibitor deficiency
  • Ch. 22. Inhibitors of tumor necrosis factor
  • Ch. 23. Targeting the IL-2 receptor with antibodies or chimeric toxins
  • Ch. 24. Monoclonal antibodies to CD3
  • Ch. 25. Anti-IgE: immunotherapy for allergic diseases
  • Ch. 26. Specific and nonspecific immunotherapy for asthma and allergic diseases
  • Ch. 27. Treatment of allergy to insect stings
  • Ch. 28. The CD28 T-Cell costimulatory pathway: pharmacologic inhibition and augmentation
  • Ch. 29. Bacterial vaccines
  • -- Ch. 30. Viral vaccines
  • Ch. 31. DNA vaccines
  • Ch. 32. Blockade of the CD40L/CD40 pathway
  • Ch. 33. Renal transplantation
  • Ch. 34. Pancreas transplantation
  • Ch. 35. Cardiac transplantation
  • Ch. 36. Lung transplantation
  • Ch 37. Hemopoietic stem cell transplantation
  • Ch. 38. Cell transplantation
  • Ch. 39. Liver transplantation
  • Ch. 40. Xenotransplantation
  • Ch. 41. Cellular therapy
  • Ch. 42. Genetically engineered cancer vaccines
  • Ch. 43. Gene therapy for inherited immunodeficiencies
  • Ch. 44. Plasmapheresis and immunoadsorption
  • Ch. 45. Drug therapy for HIV infection.
Description
xv, 655 p. : ill. ; 29 cm.
Notes
Includes bibliographical references and index.
Local Notes
HEALTH SCIENCES: Purchased with support from the Ralph Erskine Conrad Memorial Fund.
Technical Details
  • Access in Virgo Classic

  • LEADER 03667cam a22004338a 4500
    001 u3727078
    003 SIRSI
    005 20010615114201.0
    008 000601s2001 maua b 001 0 eng
    010
      
      
    a| 00044408
    020
      
      
    a| 0632043598
    035
      
      
    a| (Sirsi) o44270338
    035
      
      
    a| (Sirsi) o44270338
    035
      
      
    a| (OCoLC)44270338
    040
      
      
    a| NLM c| NLM d| TXH d| VAM
    042
      
      
    a| pcc
    049
      
      
    a| VAMM
    060
    1
    0
    a| QW 940 b| T398 2001
    090
      
      
    a| RM275 b| .T44 2001
    245
    0
    0
    a| Therapeutic immunology / c| by K. Frank Austen ... [et al.].
    250
      
      
    a| 2nd ed.
    260
      
      
    a| Malden, MA : b| Blackwell Science, c| c2001.
    300
      
      
    a| xv, 655 p. : b| ill. ; c| 29 cm.
    504
      
      
    a| Includes bibliographical references and index.
    505
    0
      
    a| Ch. 1. Adaptive immunity -- Ch. 2. Innate immunity and instruction of the adaptive immune response -- Ch. 3. Cyclophosphamide -- Ch. 4. The purine antagonists: Azathioprine and Mycophenolate Mofetil -- Ch. 5. Methotrexate -- Ch. 6. Immunosupression and immunophilin binding agents: current research and clinical applications -- Ch. 7. Glucocorticoid action -- Ch. 8. Cyclooxygenase inhibitors -- Ch. 9. Antileukotrienes (leukotriene modifiers) in the treatment of asthma -- Ch. 10. Phosphodiesterase inhibitors -- Ch. 11. Tryptase inhibitors -- Ch. 12. 5-Aminosalicylic acid (mesalamine) and sulfasalazine -- Ch. 13. Antihistamines (H₁-receptor antagonists) -- Ch. 14. Hematopoietic growth factors -- Ch. 15. Cytokines regulating immune inflammation: Interleukin-4, Interleukin-10, and Interleukin-12 -- Ch. 16. The interferons: basic biology and therapeutic potential -- Ch. 17. Interleukin-2 immunostimulation -- Ch. 18. A soluble TNF receptor-Fc fusion protein (etanercept) in the treatment inflammatory diseases -- Ch. 19. Intravenous immunoglobulin therapy -- Ch. 20. Therapeutic inhibition of complement activation with emphasis on drugs in clinical trials -- Ch. 21. Treatment of angioedema resulting from C1-inhibitor deficiency -- Ch. 22. Inhibitors of tumor necrosis factor -- Ch. 23. Targeting the IL-2 receptor with antibodies or chimeric toxins -- Ch. 24. Monoclonal antibodies to CD3 -- Ch. 25. Anti-IgE: immunotherapy for allergic diseases -- Ch. 26. Specific and nonspecific immunotherapy for asthma and allergic diseases -- Ch. 27. Treatment of allergy to insect stings -- Ch. 28. The CD28 T-Cell costimulatory pathway: pharmacologic inhibition and augmentation -- Ch. 29. Bacterial vaccines --
    505
    0
      
    a| Ch. 30. Viral vaccines -- Ch. 31. DNA vaccines -- Ch. 32. Blockade of the CD40L/CD40 pathway -- Ch. 33. Renal transplantation -- Ch. 34. Pancreas transplantation -- Ch. 35. Cardiac transplantation -- Ch. 36. Lung transplantation -- Ch 37. Hemopoietic stem cell transplantation -- Ch. 38. Cell transplantation -- Ch. 39. Liver transplantation -- Ch. 40. Xenotransplantation -- Ch. 41. Cellular therapy -- Ch. 42. Genetically engineered cancer vaccines -- Ch. 43. Gene therapy for inherited immunodeficiencies -- Ch. 44. Plasmapheresis and immunoadsorption -- Ch. 45. Drug therapy for HIV infection.
    590
      
      
    a| HEALTH SCIENCES: Purchased with support from the Ralph Erskine Conrad Memorial Fund.
    596
      
      
    a| 19
    650
      
    0
    a| Immunotherapy.
    650
    1
    2
    a| Immunotherapy.
    650
    2
    2
    a| Immune System x| drug effects.
    994
      
      
    a| E0 b| VAM
    710
    2
      
    a| Ralph Erskine Conrad Memorial Fund.
    016
    7
      
    a| 100956535 2| DNLM
    029
    0
      
    a| NLM b| 100956535
    590
      
      
    a| HEALTH SCIENCES: Purchased with support from the Ralph Erskine Conrad Memorial Fund.
    999
      
      
    a| RM275 .T44 2001 w| HS-LC i| 3470368410 l| BKSTACKS m| HEALTHSCI t| BOOK

Availability

Google Preview

Library Location Map Availability Call Number
Health Sciences Book Stacks N/A Available